Ultrasound-guided Pectoral Nerve Blocks, Thoracic Erector Spinae Plane Block and Serratus Anterior Plane Block for Breast Surgery
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Pectoral nerve block (PECS), Erector spinae plane block (ESP), Serratus anterior plane block (SAP).
- Who it may be relevant to
- Registry conditions: Ultrasound, Pectoral Nerve Blocks, Thoracic Erector Spinae Plane Block, Serratus Anterior Plane Block. Basic parameters: 21 years — 65 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Comparison Between Ultrasound-guided Pectoral Nerve Blocks, Thoracic Erector Spinae Plane Block and Serratus Anterior Plane Block for Breast Surgery: A Prospective Randomized Study
Overview
The study will compare ultrasound-guided Pectoral nerve block, Erector Spinae Plane block, and Serratus anterior plane block for pain management following elective breast surgeries
Detailed description
Adequate acute postoperative pain control is important for patients undergoing breast surgery because the pain may be severe and longlasting. Surgical incision at the breast and axillary areas is associated with significant pain, with high incidence of acute pain progressing to chronic pain in 25% to 60% of patients. Post-mastectomy pain managed with opioids often lead to side effects of nausea and vomiting.
Regional anesthetic techniques are used in the current management of pain associated with breast surgeries .They attenuate surgical stress response , intraoperative consumption of opioid, prevent central sensitization and diminish postoperative pain.
The efficacy of fascial plane blocks like pectoral nerve block (PECS), serratus anterior plane block (SAP), and erector spinae plane block (ESP) has been proven in previous studies. These blocks require deposition of local anesthetic in an inter-fascial plane through which peripheral nerves travel.
The Pectoral nerve block relies upon the deposition the local anesthetic at the inter-fascial planes among the pectoralis major, minor, and serratus anterior muscles: it blocks the pectoral, the intercostobrachial, the intercostals III and VI, and the long thoracic nerves.
Erector Spinae Plane block is another interfacial plane block. It involves deposition of local anesthetic between erector spinae muscle and transverse process of T5 vertebrae and targets both dorsal and ventral rami of thoracic spinal nerves.
Serratus anterior plane block involves the injection of local anesthetic in 1 of the 2 fascial planes, superficial and deep to serratus anterior muscle at the level of the fifth rib in midaxillary line. The SAP block targets the lateral cutaneous branches of the thoracic intercostal nerves. The deep SAP block was found to have similar analgesic efficacy and technically easier and safer to perform as compared to the superficial SAP block.
Interventions
- Drug Pectoral nerve block (PECS)
Patients will receive pectoral nerve block (PECS). - Drug Erector spinae plane block (ESP)
Patients will receive erector spinae plane block (ESP). - Drug Serratus anterior plane block (SAP)
Patients will receive serratus anterior plane block (SAP).
Primary outcome measures
- Total morphine consumption [Time frame: 24 hours postoperatively]
Secondary outcome measures (7)
- Time to the 1st rescue analgesia [Time frame: 24 hours postoperatively]
- Intraoperative fentanyl consumption [Time frame: Intraoperatively]
- Pain degree [Time frame: 24 hours postoperatively]
- Mean arterial blood pressure [Time frame: Till the end of surgery (Up to 24hours)]
- Heart rate [Time frame: Till the end of surgery (Up to 24hours)]
- Patient satisfaction [Time frame: 24 hours Postoperatively]
- Adverse effects [Time frame: 24 hours Postoperatively]
Eligibility criteria
Inclusion criteria
- Age from 21 to 65 years old female, American Society of Anesthesiologists (ASA) physical status I or II, who will undergo breast surgeries under general anesthesia.
Exclusion criteria
- Patient refusal to participate in research.
- Body Mass Index (BMI) ≥35 kg/m2.
- Sensitivity to the intervention drugs.
- Coagulation abnormalities.
- Psychiatric disorder and communication difficulties.
- Chronic neurological disease.
- Any skin infection at the needle puncture site.
- Chest wall deformity
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Tanta University — Tanta
Identifiers
NCT: NCT06947642 · 36265MD276/9/24